TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 1 Jun 2022, 12:36 BST

Official UK procurement notice

Manufacture of vaccine clinical lot

Official notice

Authority: University Of York (Pelican) (Education)

ServicesNegotiated without publication of a contract notice
Sectors: Research & Development (R&D) (73) Delivery: Yorkshire & Humber (UKE21)
Awarded value£1,072,764published contract · exc. VAT
Awarded 1 Jun 2022
Awarded to ADVENT SRL

What is being bought

Published requirement description

Manufacture of a clinical lot of leishmaniasis vaccine

CPV: Research and development services and related consultancy services

The lotProcurement structure

single lot · no lot value published
Lot #1Manufacture of a clinical lot of leishmaniasis vaccine covering; Compatability study:…

Manufacture of a clinical lot of leishmaniasis vaccine covering; Compatability study: Production and Testing of Tox Lot, Clinical Material: GMP Production and Testing of Drug Substance (DS), Clinical Material: Production and Testing of Drug Product (DP), Clinical Material:

Delivery: Yorkshire & Humber

Procedure terms & legal framework

From the official record
Procedure method
Negotiated without publication of a contract notice
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Services
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
1 Jun 2022, 12:36 BST
Last source update
1 Jun 2022, 12:36 BST
FTS notice number
2022/S 000-015336
Classification (CPV)
Research and development services and related consultancy services
Delivery area
Yorkshire & Humber (UKE21)
Official registry OCID
ocds-h6vhtk-03428e Find a Tender
Why no open competition

The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons

Published justification

The University of York (including its associated entities) intends to contract with the enclosed provider for the manufacture of a vaccine clinical lot for a 42 month period commencing 1st July 2022 without a call for competition. The University's reasons are:

  • The clinical lot is required to be compatible in manufacture with that previously used in clinical trials by the University of York, requiring manufacture using the cell line "Procell 92". The contractor were co-designers of the vaccine used in the clinical trials.
  • Only the contractor is authorised by the owners of Procell 92 (GSK) to use this cell line for manufacture of a Leishmaniasis vaccine

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £1,072,7641 contract exc. VAT
Contracts signed 1latest 1 Jun 2022
Awarded toValueDateStatus
ADVENT SRLSME£1,072,764 †—Awarded

Contracts

  • Contract 015336-2022-1 · ADVENT SRLSME

    Signed
    1 Jun 2022
    Value
    £1,072,764
    Status
    active

Contracting authority & participating public bodies

UNIVERSITY OF YORK

Contracting authorityEducationBody governed by public lawEducation Heslington, YORK, Yorkshire & Humber, YO105DDContact name, email, phone

Dispute resolution & review bodies

  • Royal Courts of JusticeReview body London

Bidders & participating suppliers

1 commercial party on the notice
  • ADVENT SRLAwarded supplier Via Pontina km 30,600 00071 Pomezia (RM), Pomezia, IT

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.